The GNL and Covid-19 Research
For more than 100 years, researchers at UTMB have been breaking ground studying new and emerging viruses.
Prior to Covid-19, UTMB already had three highly respected coronavirus researchers on staff. This helped our teams get a jump start on the development of diagnostics, anti-viral treatments and vaccines. UTMB researchers have been involved with both the Pfizer and Moderna vaccines, as well as several monoclonal antibody treatments and other therapies. In addition, when troubles arose with the early diagnostic tests, UTMB developed its own and began assisting the State of Texas with Covid tests for patients in nearly every county of the state.
Nearly one year into the pandemic, UTMB has embarked on a vigorous vaccination program in line with state and CDC guidelines. Our physicians have learned much about treating patients, and our faculty continues to be involved at the epicenter of all the important medical research.
Since March 1, 2020, UTMB research scientists have:
- Submitted 259 proposals valued at $151.4 million for research on Covid-19
- Received more than $34.3 million in funded research for Covid-19
- Published more than 130 publications in respected medical journals
- Had their work featured in more than 7,500 news articles and broadcast stories in media around the world
Media Inquiries:For media inquiries, contact UTMB Media Relations.Their 24 hour hotline is (409) 772-6397.